BioCryst Pharmaceuticals | BCRX - Market Capitalization


BioCryst Pharmaceuticals reported $1.71B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Chugai Pharma JPY 14.46T 617.89B Mar/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
DBV Technologies USD 274M 17M Sep/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Incyte USD 21.73B 3B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Novavax USD 1.09B 316M Dec/2025
PTC Therapeutics USD 4.94B 698M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.16B 123M May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026